Chemokine CCL1 as a therapeutic target for pulmonary fibrosis: comments on 'The chemokine CCL1 triggers an AMFR‒SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis'
- PMID: 34940827
- PMCID: PMC8872821
- DOI: 10.1093/jmcb/mjab080
Chemokine CCL1 as a therapeutic target for pulmonary fibrosis: comments on 'The chemokine CCL1 triggers an AMFR‒SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis'
Figures

Comment on
-
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis.Immunity. 2021 Sep 14;54(9):2042-2056.e8. doi: 10.1016/j.immuni.2021.06.008. Epub 2021 Aug 17. Immunity. 2021. PMID: 34407391
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical